BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5762678)

  • 1. A new and rapid determination of pyridinium aldoximes in blood and urine.
    Groff WA; Ellin RI
    Clin Chem; 1969 Jan; 15(1):72-83. PubMed ID: 5762678
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic analysis of imidazolium and pyridinium oximes in plasma and urine.
    Shih ML; Smith JR; Salem GW
    J Chromatogr; 1990 May; 527(2):371-9. PubMed ID: 2387884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxogonin: blood levels and side effects after intramuscular administration in man.
    Sidell FR; Groff WA
    J Pharm Sci; 1970 Jun; 59(6):793-7. PubMed ID: 5423080
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of pyridinium aldoximes - a chromatographic approach.
    Csermely T; Kalász H; Petroianu GA; Kuca K; Darvas F; Ludányi K; Mudhafar AA; Tekes K
    Curr Med Chem; 2008; 15(23):2401-18. PubMed ID: 18855669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passage of pyridinium oximes into human red cells.
    Ellin RI; Groff WA; Sidell FR
    Biochem Pharmacol; 1974 Oct; 23(19):2663-70. PubMed ID: 4417588
    [No Abstract]   [Full Text] [Related]  

  • 6. The movement of pyridinium aldoximes across the red cell membrane.
    Keen TE
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):643-53. PubMed ID: 4787503
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reactivation of cholinesterase with pyridinium aldoximes during their combined covalent immobilization in polymeric hydrogels].
    Osinkin IuA; Chupov VV; Platé NA
    Dokl Akad Nauk; 1992; 327(3):397-400. PubMed ID: 1486350
    [No Abstract]   [Full Text] [Related]  

  • 8. A liquid chromatographic-mass spectrometric (LC-MS) method for the analysis of the bis-pyridinium oxime ICD-585 in plasma: application in a guinea pig model.
    Capacio BR; Dusick B; Smith JR; McDonough JH; Shih TM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1420-5. PubMed ID: 20044318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on medicinal chemistry of K203 in wistar rats and beagle dogs.
    Kalász H; Szegi P; Jánoki G; Balogh L; Pöstényi Z; Musilek K; Petroianu GA; Siddiq A; Tekes K
    Curr Med Chem; 2013; 20(16):2137-44. PubMed ID: 23531217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS approaches for the assay of bis-quaternary pyridinium oximes used as AChE reactivators in biological matrices.
    Voicu V; Albu F; Tache F; Musilek K; Kuca K; Medvedovici A
    Bioanalysis; 2013 Apr; 5(7):793-809. PubMed ID: 23534424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spectrophotometric determination of Toxogonin in the urine and blood].
    Burger N; Smerić Z; Hankonyi V
    Arh Hig Rada Toksikol; 1984 Mar; 35(1):11-5. PubMed ID: 6391422
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Igarashi K; Castagnoli N
    J Chromatogr; 1992 Sep; 579(2):277-83. PubMed ID: 1429975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stability of pyridinium crosslinks in urine and serum.
    Walne AJ; James IT; Perrett D
    Clin Chim Acta; 1995 Aug; 240(1):95-7. PubMed ID: 8582064
    [No Abstract]   [Full Text] [Related]  

  • 14. Mini review on blood-brain barrier penetration of pyridinium aldoximes.
    Kalász H; Nurulain SM; Veress G; Antus S; Darvas F; Adeghate E; Adem A; Hashemi F; Tekes K
    J Appl Toxicol; 2015 Feb; 35(2):116-23. PubMed ID: 25291712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorimetric determination and pharmacokinetic studies of fazadinium bromide in dogs.
    Pastorino AM
    Arzneimittelforschung; 1978; 28(10):1728-30. PubMed ID: 39568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier permeability in various parts of the central nervous system.
    Aarseth P; Barstad JA
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):434-42. PubMed ID: 5715414
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction of bis-pyridinium oximes with mouse brain muscarinic receptor.
    Amitai G; Kloog Y; Balderman D; Sokolovsky M
    Biochem Pharmacol; 1980 Feb; 29(4):483-8. PubMed ID: 7370045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolism of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicetinaldoxime, 2-hydroxy-3-methoxybenzaldoxime and 4-hydroxy-5-methoxyisophthalic dioxime].
    Pham-Huu-Chanh ; Chanvattey S; Patte J
    Biochem Pharmacol; 1970 May; 19(5):1703-7. PubMed ID: 5513950
    [No Abstract]   [Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
    Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
    J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two metabolites of the cholinesterase reactivator HI-6 isolated from rat urine.
    Ligtenstein DA; Wils ER; Kossen SP; Hulst AG
    J Pharm Pharmacol; 1987 Jan; 39(1):17-23. PubMed ID: 2880978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.